Incyte to Report First Quarter Financial Results
Incyte has announced its first quarter financial results conference call, set for 8:00 a.m. ET on May 3, 2022. The call will follow a press release scheduled for 7:00 a.m. ET on the same day. Investors can join the conference via domestic and international dial-in numbers, with a conference ID of 13728884. A replay will be available for 30 days, and the live webcast will be accessible on Investor.Incyte.com for 90 days. Incyte focuses on developing therapeutics for unmet medical needs.
- Scheduled Q1 2022 press release and conference call for transparency with investors.
- Live webcast and replay options enhance accessibility for stakeholders.
- None.
The schedule for the press release and conference call/webcast is as follows:
• Q1 2022 Press Release: |
|
|||||||
• Q1 2022 Conference Call: |
|
|||||||
• Domestic Dial-In Number: |
877-407-3042 |
|||||||
• International Dial-In Number: |
201-389-0864 |
|||||||
• Conference ID Number: |
13728884 |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20220412005102/en/
Media
+1 302 498 6171
cloveman@incyte.com
Investors
+1 302 274 4773
cchiou@incyte.com
Source:
FAQ
When will Incyte report its Q1 2022 financial results?
What time is Incyte's Q1 2022 conference call?
How can I access Incyte's conference call?
Is there a way to listen to a replay of Incyte's conference call?